The global healthcare expenditure accounted approximately $7 trillion in 2015 and is expected to reach $8.5 trillion, by the year 2020. Increase in the geriatric population has escalated the need for devices, which can monitor the disease, continuously. The biosensing technologies are anticipated to address the healthcare expenditure problem. According to the latest market intelligence report by BIS Healthcare titled, ‘Global Biosensors Market- Analysis and Forecast (2018-2027),’ the biosensors market was estimated $ 1.46 billion in the year 2017. The biosensors market is expected to reach on a niche level by the year 2027 owing to the growing point of care testing services, aided by rising geriatric population, and rapid incorporation of biosensing technologies in non-medical applications.